Recombinant Saccharomyces cerevisiae Protein SVP26 (SVP26)

What is SVP26 in Saccharomyces cerevisiae?

SVP26 is a polytopic integral membrane protein found in the endoplasmic reticulum (ER) and early Golgi compartment of Saccharomyces cerevisiae . It functions as an ER exit adaptor protein that facilitates the transport of specific mannosyltransferases from the ER to the Golgi apparatus. Structurally, SVP26 contains four predicted transmembrane segments and plays a critical role in maintaining proper localization of several Golgi-resident enzymes . The protein was first discovered during a global inspection of membrane proteins in the early Golgi compartment, where researchers observed that its deletion led to phenotypic changes in glycosylation patterns and enzyme localization .

SVP26 works by selectively incorporating certain mannosyltransferases into COPII vesicles, which are responsible for anterograde transport from the ER to the Golgi . This selective cargo recognition and facilitation represents a fundamental mechanism for protein sorting in the early secretory pathway.

Where is SVP26 localized in yeast cells?

SVP26 exhibits dual localization, being present in both the ER and early Golgi compartment . Initially, researchers favored a model where SVP26 was exclusively Golgi-localized, but subsequent studies using subcellular fractionation techniques revealed a more complex distribution pattern. When wild-type cell lysate was fractionated by sucrose density gradient centrifugation, SVP26 was found in two peak fractions corresponding to the ER and early Golgi compartments .

The presence of SVP26 in the ER is functionally significant as it enables the protein to assist cargo molecules at their point of origin before transport. This dual localization is consistent with its role as an adaptor protein that facilitates the incorporation of specific mannosyltransferases into COPII vesicles at ER exit sites . Understanding this localization pattern is crucial for interpreting the function of SVP26 in the secretory pathway.

What experimental approaches are most effective for studying SVP26 structure and topology?

When studying SVP26 structure and topology, researchers should implement multiple complementary approaches to generate robust data. Begin with computational prediction tools to identify potential transmembrane domains, followed by experimental verification using protease protection assays to determine which regions are exposed to the cytoplasm versus the lumen . Topology mapping can be effectively achieved through the strategic insertion of epitope tags or glycosylation sites at various positions in the protein sequence.

For more detailed structural analysis, researchers should consider:

• Cysteine scanning mutagenesis to identify accessibility of specific residues

• Fluorescence resonance energy transfer (FRET) to measure distances between domains

• Limited proteolysis combined with mass spectrometry to identify domain boundaries

• Crosslinking studies to capture interactions between transmembrane segments

The current experimental evidence indicates that SVP26 has four transmembrane segments with both N-terminal and C-terminal domains facing the cytoplasm . This topology is consistent with its proposed function as an adaptor protein that interacts with both cargo proteins in the ER lumen and components of the COPII coat on the cytoplasmic face of the membrane.

What phenotypes are associated with SVP26 deletion?

The deletion of SVP26 (Δsvp26) results in several distinct phenotypes that provide insights into its cellular function:

Despite these phenotypes, SVP26 is not essential for yeast viability, indicating that compensatory mechanisms exist or that its function becomes critical only under specific conditions . The phenotypes are cargo-specific, affecting only a subset of mannosyltransferases, which suggests that SVP26 has evolved for selective cargo recognition rather than as a general component of the ER export machinery.

How is SVP26 expression regulated in response to cellular stress?

• Quantitative PCR analysis of SVP26 mRNA levels under different stress conditions (ER stress, nutrient limitation, temperature shifts)

• Western blot analysis to monitor protein levels with specific anti-SVP26 antibodies

• Promoter-reporter assays to identify regulatory elements controlling SVP26 transcription

• Chromatin immunoprecipitation to identify transcription factors binding to the SVP26 promoter

Researchers should design experiments comparing SVP26 expression levels in wild-type cells exposed to various stressors, including:

• ER stress inducers (tunicamycin, DTT, thapsigargin)

• Temperature stress (heat shock, cold shock)

• Osmotic stress

• Nutrient limitation

These experiments would provide valuable insights into how SVP26-mediated transport is regulated in response to changing cellular conditions and might reveal additional functions of SVP26 beyond its role in constitutive transport.

What is the primary function of SVP26 in yeast cells?

The primary function of SVP26 is to act as an ER exit adaptor protein that facilitates the selective incorporation of specific mannosyltransferases into COPII vesicles for transport from the ER to the Golgi apparatus . This function ensures the proper localization of these enzymes in the Golgi compartments, which is essential for normal glycosylation processes.

Mechanistically, SVP26 functions by:

• Recognizing and binding to specific cargo proteins, particularly mannosyltransferases, in the ER membrane

• Enhancing the efficiency of cargo incorporation into COPII vesicles, as demonstrated by in vitro budding assays

• Potentially interacting with components of the COPII coat to promote vesicle formation and cargo selection

• Potentially regulating the enzymatic activity of its cargo proteins, as suggested by the hypermannosylation phenotype observed in Δsvp26 cells

Without SVP26, specific mannosyltransferases fail to efficiently exit the ER, leading to their accumulation in this compartment and consequent alterations in protein glycosylation patterns . The identification of this adaptor function provides important insights into how protein sorting specificity is achieved in the early secretory pathway.

Which proteins interact with SVP26 and how can these interactions be detected?

SVP26 interacts with several mannosyltransferases and potentially other proteins in the secretory pathway. The following table summarizes the known interaction partners:

To detect these interactions, researchers should employ multiple complementary approaches:

• Co-immunoprecipitation (co-IP): Use digitonin for solubilization to preserve weaker interactions that may be disrupted by stronger detergents like Triton X-100 . The choice of detergent is critical, as demonstrated by the fact that some interactions are only detected with digitonin but not with Triton X-100 .

• Proximity labeling approaches: BioID or APEX2 fused to SVP26 can identify proteins in close proximity in vivo.

• Fluorescence-based interaction assays: Bimolecular fluorescence complementation (BiFC) or FRET can detect interactions in living cells.

• Cross-linking mass spectrometry: This can capture transient interactions and identify specific contact residues.

• Split-ubiquitin yeast two-hybrid system: Particularly useful for studying interactions between membrane proteins.

The strength and specificity of these interactions likely determine which cargo proteins depend on SVP26 for efficient ER exit and proper Golgi localization.

How does SVP26 facilitate the incorporation of mannosyltransferases into COPII vesicles?

SVP26 facilitates the incorporation of specific mannosyltransferases into COPII vesicles through a mechanism that significantly enhances their transport efficiency. In vitro budding assays have provided direct evidence for this function by demonstrating that the presence of SVP26 greatly stimulates the incorporation of Ktr3 and Mnn2 into COPII vesicles .

The molecular mechanism involves several steps:

• Recognition and binding of cargo proteins: SVP26 specifically binds to the lumenal domains of mannosyltransferases like Ktr3, Mnn2, and Mnn5 .

• Efficient COPII vesicle incorporation: SVP26 itself is efficiently packaged into COPII vesicles, suggesting it contains signals that are recognized by the COPII machinery .

• Co-recruitment of cargo: The binding of SVP26 to its cargo proteins likely enables their co-recruitment into COPII vesicles, functioning as an adaptor that bridges cargo and coat proteins.

• Selectivity in cargo recognition: SVP26 selectively facilitates the transport of specific mannosyltransferases but not others, indicating a specialized role in cargo selection .

This mechanism ensures the efficient exit of specific glycosylation enzymes from the ER and their delivery to their functional location in the Golgi apparatus, which is essential for proper protein glycosylation in the cell.

What domains of cargo proteins are recognized by SVP26?

Domain-swapping experiments have revealed that the lumenal domains of mannosyltransferases, rather than their cytoplasmic or transmembrane domains, are responsible for recognition by SVP26 . This finding is significant because the lumenal domain typically functions as the catalytic domain of these enzymes .

The following table summarizes the results of domain-swapping experiments:

These results indicate that when the lumenal domain of an SVP26-dependent protein (like Ktr3 or Mnn2) is replaced with that of an SVP26-independent protein (like Mnn1), the chimeric protein no longer depends on SVP26 for ER exit . Conversely, when the lumenal domain of an SVP26-independent protein is replaced with that of an SVP26-dependent protein, the chimeric protein acquires SVP26 dependence .

The specific structural features or motifs within these lumenal domains that are recognized by SVP26 remain to be identified. Understanding these recognition elements would provide deeper insights into the selectivity of SVP26-mediated transport.

How does SVP26 affect protein glycosylation in yeast?

The influence of SVP26 on protein glycosylation occurs through its role in maintaining the proper localization of specific mannosyltransferases. When SVP26 is deleted, several important observations regarding glycosylation patterns have been made:

• Hypermannosylation: Δsvp26 cells exhibit abnormal hypermannosylation of N-glycosyl chains on proteins such as invertase and modified hen egg lysozyme . This suggests that the mislocalization of mannosyltransferases disrupts the normal regulation of glycosylation processes.

• Altered glycan structure: The specific structural changes in glycans resulting from SVP26 deletion should be characterized using mass spectrometry-based glycomics approaches. This would provide insights into which glycosidic linkages are affected.

• Potential mechanisms:

  • Mislocalized mannosyltransferases in the ER may add mannose residues prematurely

  • Enzymes that do reach the Golgi via alternative pathways may function without normal regulatory constraints

  • The relative activities or concentrations of different mannosyltransferases across compartments may be altered

• Functional consequences: These altered glycosylation patterns potentially affect protein folding, stability, trafficking, and function, which could have wide-ranging effects on cellular processes.

To properly study these effects, researchers should implement a comprehensive glycomics approach, combining genetic manipulation of SVP26 with detailed structural analysis of the resulting glycans using techniques such as mass spectrometry and nuclear magnetic resonance spectroscopy.

What in vitro assays are most informative for studying SVP26 function?

The in vitro COPII vesicle budding assay represents the gold standard for directly assessing SVP26 function in facilitating cargo exit from the ER . This assay measures the incorporation of cargo proteins into COPII vesicles and has been instrumental in demonstrating that SVP26 enhances the efficiency of this process for specific mannosyltransferases.

• Membrane preparation:

  • Isolate ER-enriched membrane fractions from wild-type and Δsvp26 cells

  • Normalize protein concentration between samples

• Vesicle formation reaction:

  • Incubate membranes with purified COPII components (Sar1p, Sec23p/24p, Sec13p/31p)

  • Add GTP and ATP regeneration system

  • Include control reactions lacking COPII components or GTP

• Vesicle isolation:

  • Perform differential centrifugation to separate vesicles from donor membranes

  • Carefully collect the supernatant containing COPII vesicles

• Analysis:

  • Assess cargo incorporation by Western blotting

  • Quantify the amount of specific cargo proteins in vesicle fractions

  • Compare packaging efficiency between wild-type and Δsvp26 conditions

The results from such experiments show that for SVP26-dependent cargo like Ktr3 and Mnn2, incorporation into COPII vesicles is significantly reduced in membranes lacking SVP26 . This provides direct evidence for SVP26's role as an ER exit adaptor for these specific proteins.

How can researchers effectively visualize SVP26 and its cargo proteins in vivo?

Visualizing SVP26 and its cargo proteins in live cells requires careful experimental design to overcome challenges such as low expression levels and dynamic localization patterns. A comprehensive approach would include:

• Fluorescent protein tagging:

  • Generate C-terminal or N-terminal fusions with appropriate fluorescent proteins

  • Verify that tagging does not disrupt protein function

  • Use bright, photostable fluorophores such as mNeonGreen or mScarlet

  • Consider sandwich tagging for proteins where terminal tagging affects function

• Imaging parameters:

  • Use high-sensitivity cameras and optimal exposure settings

  • Implement deconvolution or super-resolution techniques for better spatial resolution

  • Perform time-lapse imaging to capture dynamic events

  • Use appropriate organelle markers for colocalization studies

• Quantitative analysis:

  • Measure colocalization coefficients between SVP26 and its cargo

  • Quantify the relative distribution across compartments

  • Track changes in localization over time or after perturbations

• Validation approaches:

  • Compare imaging results with biochemical fractionation data

  • Use conditional mutants to synchronize trafficking events

  • Perform fluorescence recovery after photobleaching (FRAP) to measure protein dynamics

For SVP26 specifically, researchers should be aware that its signal intensity per unit area in the ER may be lower than in the Golgi, making detection challenging by standard fluorescence microscopy . Employing signal enhancement techniques or more sensitive detection methods may be necessary to visualize the complete distribution pattern.

What genetic approaches can be used to study SVP26 function in vivo?

Genetic manipulation provides powerful tools for investigating SVP26 function in the context of the living cell. Researchers should consider implementing the following approaches:

• Gene deletion and complementation:

  • Generate Δsvp26 knockout strains using homologous recombination

  • Complement with wild-type SVP26 expressed from plasmids

  • Use different promoters to modulate expression levels

  • Create point mutants to identify functional residues

• Domain analysis:

  • Create truncation mutants to identify functional domains

  • Generate chimeric proteins with other membrane proteins

  • Introduce specific mutations in predicted functional regions

  • Employ alanine-scanning mutagenesis across the protein sequence

• Synthetic genetic interactions:

  • Perform synthetic genetic array (SGA) analysis with Δsvp26

  • Identify genetic suppressors or enhancers of svp26 phenotypes

  • Create double mutants with other trafficking components

  • Test for functional redundancy with other potential adaptor proteins

• Conditional alleles:

  • Generate temperature-sensitive or auxin-inducible degron alleles

  • Create versions with regulatable expression

  • Employ rapid conditional inactivation systems (e.g., anchor-away)

  • Use these tools to study acute loss of SVP26 function

• Cargo protein analysis:

  • Create reporter constructs for tracking SVP26-dependent cargo

  • Develop screening systems to identify additional SVP26 cargo

  • Generate cargo variants to map interaction determinants

These genetic approaches should be coupled with appropriate functional assays, such as monitoring glycosylation patterns, protein localization, and in vitro transport assays to comprehensively characterize SVP26 function.

How should researchers design experiments to study SVP26-dependent transport?

Designing robust experiments to study SVP26-dependent transport requires careful consideration of controls, quantification methods, and experimental parameters. A comprehensive experimental design should include:

• Strain selection and validation:

  • Use isogenic strains differing only in SVP26 status

  • Include multiple independent clones to control for clonal variations

  • Verify SVP26 expression levels in complemented strains

  • Use fluorescently tagged strains validated for normal function

• Cargo selection strategy:

  • Include known SVP26-dependent cargoes (Ktr3, Mnn2, Mnn5)

  • Include SVP26-independent control cargoes (Mnn1, Mnn9)

  • Test novel candidate cargoes with similar characteristics

  • Consider chimeric proteins to map interaction domains

• Transport assays:

  • Implement pulse-chase experiments to track cargo movement kinetics

  • Measure ER-to-Golgi transport rates using glycosylation as a readout

  • Perform subcellular fractionation to quantify protein distribution

  • Use live-cell imaging to visualize transport in real-time

• Perturbation approaches:

  • Test transport under stress conditions

  • Use temperature shifts with conditional mutants

  • Apply pharmacological inhibitors of trafficking

  • Deplete or overexpress potential regulators

• Quantitative analysis:

  • Use multiple technical and biological replicates

  • Apply appropriate statistical tests

  • Quantify both steady-state distributions and transport kinetics

  • Develop mathematical models of SVP26-dependent transport

When interpreting results, researchers should consider that even in the absence of SVP26, a small amount of SVP26-dependent mannosyltransferase can reach the Golgi through alternative pathways . This "leakiness" should be accounted for in quantitative analyses and may provide insights into secondary transport mechanisms.

What biochemical methods are most effective for purifying and characterizing SVP26?

Purification and biochemical characterization of SVP26 present significant challenges due to its multiple transmembrane domains and membrane-embedded nature. The following methodological approach is recommended:

• Expression strategies:

  • Use homologous expression in yeast for native-like protein

  • Consider heterologous expression in insect cells for higher yields

  • Add affinity tags (His, FLAG, Strep-tag II) for purification

  • Evaluate multiple tag positions to find optimal configuration

  • Consider fusion constructs with solubility-enhancing partners

• Membrane extraction:

  • Test multiple detergents (digitonin, DDM, LMNG, GDN)

  • Optimize detergent concentration and buffer conditions

  • Consider nanodiscs or SMALPs for detergent-free extraction

  • Evaluate lipid composition effects on stability

• Purification protocol:

  • Implement multi-step purification (affinity, size exclusion, ion exchange)

  • Monitor protein homogeneity by SDS-PAGE and size exclusion chromatography

  • Verify protein identity by mass spectrometry

  • Assess protein stability using thermal shift assays

• Functional characterization:

  • Develop binding assays with purified cargo protein domains

  • Measure binding kinetics using surface plasmon resonance or bio-layer interferometry

  • Establish proteoliposome reconstitution systems

  • Perform in vitro vesicle budding assays with reconstituted components

• Structural studies:

  • Attempt crystallization trials with various detergents and lipid additives

  • Consider cryo-electron microscopy for structure determination

  • Use hydrogen-deuterium exchange mass spectrometry to map interaction interfaces

  • Apply crosslinking mass spectrometry to identify proximity relationships

For initial characterization, researchers might focus on purifying stable SVP26-cargo complexes rather than SVP26 alone, as the complex may exhibit greater stability and provide additional insights into the molecular basis of cargo recognition.

How does SVP26 selectivity for cargo proteins work at the molecular level?

The molecular basis for SVP26's selective recognition of specific mannosyltransferases represents a fascinating area for investigation. Based on current evidence, several hypotheses can be proposed and tested:

• Structural recognition hypothesis:
  SVP26 may recognize specific three-dimensional structural motifs in the lumenal domains of its cargo proteins rather than linear sequence motifs . This would explain how SVP26 can bind to proteins with different molecular masses and limited sequence homology .

• Conformational selection mechanism:
  SVP26 might preferentially bind to specific conformational states of cargo proteins, potentially influencing their folding or stability in addition to their transport.

• Cooperative binding model:
  Initial binding to one region of the cargo protein might induce conformational changes in SVP26 that enhance binding to additional regions, creating a high-affinity, specific interaction.

To investigate these possibilities, researchers should:

• Perform alanine-scanning mutagenesis across the lumenal domains of cargo proteins

• Use hydrogen-deuterium exchange mass spectrometry to map interaction interfaces

• Create minimal binding domains through systematic truncation analysis

• Apply computational modeling to predict interaction surfaces

• Develop high-throughput binding assays to screen cargo variants

Understanding the molecular basis of selectivity would not only advance our knowledge of SVP26 function but could also provide insights into general principles of cargo recognition in the secretory pathway.

What is the relationship between SVP26 and glycosylation quality control mechanisms?

The observation that Δsvp26 cells exhibit abnormal hypermannosylation of N-glycosyl chains raises intriguing questions about the relationship between SVP26 and glycosylation quality control mechanisms. This relationship could operate through several potential mechanisms:

• Spatial regulation hypothesis:
  SVP26 may ensure the proper compartmentalization of mannosyltransferases, preventing premature glycosylation in the ER and maintaining the sequential nature of glycan processing.

• Enzymatic activity modulation:
  The interaction between SVP26 and mannosyltransferases might directly affect their enzymatic activity, with SVP26 potentially serving as a negative regulator that controls the degree of mannosylation .

• Integration with folding quality control:
  SVP26-mediated transport may be coordinated with protein folding quality control mechanisms to ensure that only properly folded glycoproteins progress through the secretory pathway.

To investigate these hypotheses, researchers could:

• Compare glycan structures between wild-type and Δsvp26 cells using mass spectrometry

• Assess the enzymatic activity of purified mannosyltransferases in the presence and absence of SVP26

• Examine the timing of mannosyltransferase transport relative to substrate protein folding

• Test for genetic interactions between SVP26 and known glycosylation quality control components

• Develop in vitro reconstitution systems to directly test the effect of SVP26 on mannosyltransferase activity

Understanding this relationship could provide valuable insights into how cells coordinate protein transport with glycosylation quality control.

How does the COPII machinery recognize SVP26 and its cargo complexes?

The mechanism by which the COPII machinery recognizes and incorporates SVP26 and its cargo complexes into vesicles represents a central question in understanding SVP26's function as an adaptor protein. Several models can be proposed:

• Direct interaction model:
  SVP26 may contain cytoplasmic motifs that directly interact with COPII coat components such as Sec24, similar to other cargo receptors.

• Cooperative binding mechanism:
  The SVP26-cargo complex might form a binding interface that is collectively recognized by COPII components, with neither SVP26 nor cargo alone being sufficient for efficient recognition.

• Conformational activation hypothesis:
  Binding of cargo to SVP26 could induce conformational changes that expose or create COPII binding sites on SVP26.

To dissect these possibilities, researchers should:

• Perform yeast two-hybrid or pull-down assays to test direct interactions between SVP26 and COPII components

• Create chimeras between SVP26 and other membrane proteins to map COPII recognition domains

• Use site-directed mutagenesis to identify critical residues for COPII interaction

• Develop in vitro reconstitution assays with purified components

• Apply structural approaches to visualize the SVP26-cargo-COPII interface

Understanding this recognition process would provide insights into how adaptor proteins like SVP26 contribute to the specificity of cargo selection in COPII vesicles.

How is SVP26 function regulated in response to cellular needs?

The regulation of SVP26 function in response to changing cellular conditions remains poorly understood but represents an important aspect of its biology. Several potential regulatory mechanisms can be investigated:

• Expression-level regulation:
  SVP26 expression might be modulated in response to ER stress, changes in glycosylation demands, or alterations in the secretory pathway.

• Post-translational modifications:
  SVP26 function could be regulated through phosphorylation, ubiquitination, or other modifications that affect its interaction with cargo or COPII components.

• Competitive binding:
  Different cargo proteins might compete for binding to SVP26, creating a system where transport priorities can be shifted based on relative abundance or affinity.

• Compartment-specific regulation:
  SVP26 function might be differentially regulated in the ER versus the Golgi through compartment-specific factors or conditions.

To investigate these possibilities, researchers should:

• Analyze SVP26 expression levels under various stress conditions

• Map post-translational modifications using mass spectrometry

• Test for competition between different cargo proteins for SVP26 binding

• Examine the effect of ER and Golgi environmental factors on SVP26-cargo interactions

• Screen for regulators using genetic or physical interaction approaches

Understanding how SVP26 function is regulated would provide insights into how cells adapt their secretory transport systems to changing conditions.

What are the implications of SVP26 research for understanding human trafficking disorders?

Although SVP26 is a yeast protein, research on its function has potential implications for understanding protein trafficking disorders in humans. Several connections can be drawn:

• Evolutionary conservation of mechanisms:
  The fundamental mechanisms of adaptor-mediated cargo selection are likely conserved from yeast to humans, making SVP26 a valuable model system.

• Glycosylation disorders:
  Many human congenital disorders of glycosylation involve defects in glycosyltransferase localization or function, similar to the effects observed in Δsvp26 yeast .

• Trafficking component homologs:
  Identifying human homologs or functional analogs of SVP26 could provide candidate genes for trafficking disorders.

• Therapeutic strategies:
  Understanding how adaptor proteins like SVP26 facilitate enzyme transport could suggest therapeutic approaches for diseases involving enzyme mislocalization.

To explore these connections, researchers could:

• Conduct comparative genomic analyses to identify potential human homologs of SVP26

• Test whether human glycosyltransferases depend on specific adaptor proteins for proper localization

• Examine whether mutations in putative human adaptor proteins are associated with glycosylation disorders

• Develop screening systems in yeast to test the function of human trafficking proteins

By establishing these connections, SVP26 research could contribute to our understanding of human disease mechanisms and potentially lead to new therapeutic approaches.

What are the most significant unanswered questions in SVP26 research?

Despite significant progress in understanding SVP26 function, several key questions remain unanswered that represent important directions for future research:

• Molecular recognition mechanism:
  What specific structural features in the lumenal domains of cargo proteins are recognized by SVP26, and how does this recognition occur at the molecular level?

• Regulatory mechanisms:
  How is SVP26 function regulated in response to changing cellular conditions, and what factors control its activity or specificity?

• Structural insights:
  What is the three-dimensional structure of SVP26, and how does this structure change upon cargo binding or interaction with COPII components?

• Comprehensive cargo identification:
  What is the complete set of proteins that depend on SVP26 for efficient ER exit, and what common features do they share?

• Termination mechanism:
  How and when does the interaction between SVP26 and its cargo proteins end after arrival in the Golgi compartment, and what effect does this have on enzyme activity?

Addressing these questions will require integrated approaches combining genetics, biochemistry, cell biology, structural biology, and systems biology. The answers will not only advance our understanding of SVP26 specifically but also provide broader insights into the mechanisms of protein sorting in the secretory pathway.

How can researchers integrate multiple experimental approaches to advance SVP26 research?

Advancing our understanding of SVP26 function requires the integration of multiple experimental approaches to create a comprehensive picture. A strategic research program should include:

• Systematic cargo identification:
  Combine proteomics, genetic screens, and localization studies to identify the complete set of SVP26-dependent cargoes.

• Structure-function analysis:
  Integrate structural biology approaches with functional assays to relate SVP26 structure to its cargo recognition and adaptor functions.

• In vivo dynamics:
  Use advanced imaging techniques to visualize SVP26-cargo interactions and transport events in real-time in living cells.

• In vitro reconstitution:
  Develop minimal reconstituted systems to directly test mechanistic hypotheses about SVP26 function.

• Systems-level integration: Place SVP26 in the broader context of the secretory pathway through network analysis and mathematical modeling.